KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Inventory (2016 - 2026)

Neogenomics filings provide 17 years of Inventory readings, the most recent being $29.8 million for Q1 2026.

  • On a quarterly basis, Inventory changed 0.22% to $29.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $29.8 million, a 0.22% change, with the full-year FY2025 number at $28.6 million, up 6.8% from a year prior.
  • Inventory hit $29.8 million in Q1 2026 for Neogenomics, up from $28.6 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $34.2 million in Q2 2025 to a low of $20.3 million in Q1 2024.
  • Median Inventory over the past 5 years was $24.4 million (2023), compared with a mean of $25.7 million.
  • Biggest five-year swings in Inventory: fell 16.83% in 2024 and later soared 47.2% in 2025.
  • Neogenomics' Inventory stood at $24.3 million in 2022, then fell by 0.5% to $24.2 million in 2023, then increased by 10.73% to $26.7 million in 2024, then rose by 6.8% to $28.6 million in 2025, then grew by 4.45% to $29.8 million in 2026.
  • The last three reported values for Inventory were $29.8 million (Q1 2026), $28.6 million (Q4 2025), and $28.5 million (Q3 2025) per Business Quant data.